Researchers sought to determine whether daratumumab monotherapy could be effective in delaying progression of SMM.

Researchers investigated the long-term of safety and efficacy of subcutaneously injected pertuzumab and trastuzumab in patients with HER2-positive early breast cancer.

The study results “indicate that the public has certain reservations about the integration of AI in health care,” the researchers wrote.

HealthDay News — Cannabis use disorder (CUD) is associated with an increased risk for oral cancer, according to a study published in the September issue of Preventive Medicine Reports.

CLL-314 trial compared the efficacy and safety of pirtobrutinib with ibrutinib in adults with CLL/SLL who were treatment-naïve or who were previously treated and were BTK inhibitor-naïve.

Researchers assessed the effect of liver transplant on colon dysplasia and colorectal cancer among individuals with concomitant PSC and IBD.

Although this was a negative study, I think the data shown here contribute to our knowledge of IO treatments in urothelial cancer,” said Michiel Van der Heijden, MD, PhD.

HealthDay News — In-person offers of self-sampling cervical cancer screening kits are most effective, according to a study published online July 29 in eClinicalMedicine.

Atrial fibrillation was reported in 10 acalabrutinib-treated patients compared with 120 patients undergoing chemoimmunotherapy, demonstrating significantly lower odds.

At 25 years, the prostate cancer-specific survival rate was 94% among men with screen-detected prostate cancer who chose primary active surveillance – but prostate cancer progression rates are high.

The first trial of adjuvant platinum-based chemotherapy plus paclitaxel in patients with high-risk penile cancer provided some insights.

Investigators presented an interim analysis of the phase 3 ENLIGHTED trial of photodynamic therapy in patients with low-grade upper-tract urothelial cancer.